Fireside Chat: Leading Innovation with Impact - October 23, 2025

Dr. Stanley T. Crooke, Founder, Chairman and CEO of n-Lorem Foundation

Moderated by Fred Ledley

Biopharmaceutical innovation requires both scientific breakthroughs and bold business models to bring new medicines to patients. Dr. Stanley Crooke, founder and longtime CEO of lonis Pharmaceuticals, has been a pioneering leader in this work for more than 40 years. In this fireside chat, he shares lessons from the technological and business innovations that led to more than 20 drug approvals, as well as his latest venture, the n-Lorem Foundation, a nonprofit focused on developing treatments for individuals with 1nano-rare1 diseases.

Dr. Stanley T. Crooke is Founder, Chairman and CEO of n-Lorem Foundation, a nonprofit focused on discovering, developing and providing personalized, experimental treatments for nanorare patients (1 to 30 patients worldwide). Prior, Dr. Crooke founded, was Chairman, CEO and Lead Scientist of lonis Pharmaceuticals, where he led the scientific development of a new platform for drug discovery, antisense oligonucleotide (ASO) technology and the creation of one of the largest development pipelines in the biotechnology industry. Dr. Crooke received his M.D. and Ph.D. degrees and house staff training at Baylor College of Medicine, where he currently serves on the Board of Advisors. He has published 600 scientific publications, edited more than 20 books, has numerous patents, and led the development of more than 23 commercialized drugs.